Zacks Investment Management Organon & Co. Transaction History

Zacks Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $168,113 - $211,562	9,634 Added 6.84%	150,531 $3.12 Million
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $1.94 Million - $2.65 Million	140,897 New	140,897 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $131,437 - $192,382	-5,617 Reduced 1.9%	290,356 $6.8 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $312,325 - $383,748	9,865 Added 3.45%	295,973 $9.99 Million
Q1 2022 May 13, 2022	BUY	$30.45 - $39.36 $731,439 - $945,466	24,021 Added 9.17%	286,108 $9.99 Million
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $100,574 - $130,252	-3,508 Reduced 1.32%	262,087 $7.98 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $6.94 Million - $8.63 Million	242,266 Added 1038.48%	265,595 $8.71 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $663,710 - $886,502	23,329 New	23,329 $706,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.